Identification of Three Novel and One Known Mutation in the WFS1 Gene in Four Unrelated Turkish Families: The Role of Homozygosity Mapping in the Early Diagnosis
Authors:
- Maha SherifMSMaha Sherif
- Hüseyin DemirbilekHDHüseyin Demirbilek
- Atilla ÇayırAÇAtilla Çayır
- Sophia TahirSTSophia Tahir
- Büşra ÇavdarlıBÇBüşra Çavdarlı
- Meliha DemiralMDMeliha Demiral
- Ayşe Nurcan CebeciACAyşe Nurcan Cebeci
- Doğuş VurallıDVDoğuş Vurallı
- Sofia Asim RahmanSRSofia Asim Rahman
- Edip UnalEUEdip Unal
- Gönül BüyükyılmazGBGönül Büyükyılmaz
- Riza Taner BaranRBRiza Taner Baran
Open Access
- 26 February 2021
- journal article
- research article
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 13 (1) , 34-43
Abstract
Bi-allelic mutations in the wolframin gene (WFS1) cause Wolfram syndrome 1 (WS1 or DIDMOAD) characterized by non-autoimmune diabetes mellitus, optic atrophy, diabetes insipidus, sensorineural deafness, urinary tract abnormalities, and neuropsychiatric disorders. Patients presenting with an incomplete phenotype of WS1 were evaluated using homozygosity mapping and subsequent whole-exome sequencing. Four unrelated consanguineous Turkish families, including seven affected children, and their unaffected parents and siblings were evaluated. Homozygosity mapping was performed, followed by whole-exome sequencing of WFS1. Mutations were classified according to results of “in silico” analyses, protein prediction, and functional consequences. Homozygosity mapping confirmed shared homozygous regions on chromosome 4 (chr4p16.1) between the affected individuals, that was absent in their unaffected siblings. Exome sequencing identified three novel (c.1215T>A, c.554G>A, c.1525_1540dup) and one known (c.1522_1523delTA) mutations in WFS1. All mutations were predicted to cause stop codon leading to early termination of protein synthesis and complete loss-of-function. All patients were found to be homozygous for the change, with parents and other unaffected siblings being carriers. Our study expands the mutation spectrum of WSF1 mutations with three novel mutations. Homozygosity mapping may provide enrichment for molecular genetic analysis and early diagnosis of WS1 patients with incomplete phenotype, particularly in consanguineous pedigrees.Keywords
This publication has 24 references indexed in Scilit:
- Rapidly progressive renal disease as part of Wolfram syndrome in a large inbred Turkish family due to a novel WFS1 mutation (p.Leu511Pro)European Journal of Medical Genetics, 2012
- Diabetes and Neurodegeneration in Wolfram SyndromeDiabetes Care, 2011
- The E3 Ligase Smurf1 Regulates Wolfram Syndrome Protein Stability at the Endoplasmic ReticulumJournal of Biological Chemistry, 2011
- Endoplasmic reticulum stress in β-cells and development of diabetesCurrent Opinion in Pharmacology, 2009
- One step at a time: endoplasmic reticulum-associated degradationNature Reviews Molecular Cell Biology, 2008
- Signal integration in the endoplasmic reticulum unfolded protein responseNature Reviews Molecular Cell Biology, 2007
- Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1Cell Metabolism, 2006
- Disruption of the WFS1 gene in mice causes progressive -cell loss and impaired stimulus-secretion coupling in insulin secretionHuman Molecular Genetics, 2004
- Homozygosity Mapping Identifies an Additional Locus for Wolfram Syndrome on Chromosome 4qThe American Journal of Human Genetics, 2000
- Nonsense-mediated mRNA decayin health and diseaseHuman Molecular Genetics, 1999